{"id":"https://openalex.org/W2889569424","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.7031","title":"Phase 1 trial of pegzilarginase in patients (pts) with relapsed/refractory (R/R) AML or MDS refractory to hypomethylating agents (HMAs).","display_name":"Phase 1 trial of pegzilarginase in patients (pts) with relapsed/refractory (R/R) AML or MDS refractory to hypomethylating agents (HMAs).","publication_year":2018,"publication_date":"2018-05-20","ids":{"openalex":"https://openalex.org/W2889569424","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.7031","mag":"2889569424"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.15_suppl.7031","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.7031","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.7031","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101423957","display_name":"Geoffrey L. Uy","orcid":"https://orcid.org/0000-0002-7809-0996","observed_orcids":["https://orcid.org/0000-0002-7809-0996"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Geoffrey L. Uy","raw_affiliation_strings":["Washington University School of Medicine, St. Louis, MO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University School of Medicine, St. Louis, MO;","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049400849","display_name":"Michael Robert Savona","orcid":"https://orcid.org/0000-0003-3763-5504","observed_orcids":["https://orcid.org/0000-0003-3763-5504"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael R. Savona","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, TN;","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082911627","display_name":"Benjamin Kent Tomlinson","orcid":"https://orcid.org/0000-0002-2407-0973","observed_orcids":["https://orcid.org/0000-0002-2407-0973"]},"institutions":[{"id":"https://openalex.org/I4210108791","display_name":"University Hospitals Cleveland Medical Center","ror":"https://ror.org/01gc0wp38","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]},{"id":"https://openalex.org/I4210119077","display_name":"University Hospitals Seidman Cancer Center","ror":"https://ror.org/02kb97560","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210119077"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin K. Tomlinson","raw_affiliation_strings":["Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH;","institution_ids":["https://openalex.org/I4210108791","https://openalex.org/I4210119077"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016810759","display_name":"Hetty E. Carraway","orcid":"https://orcid.org/0000-0001-5241-3614","observed_orcids":["https://orcid.org/0000-0001-5241-3614"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hetty Carraway","raw_affiliation_strings":["Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103245321","display_name":"Dale Lee Bixby","orcid":"https://orcid.org/0000-0001-6885-8239","observed_orcids":["https://orcid.org/0000-0001-6885-8239"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dale L. Bixby","raw_affiliation_strings":["Comprehensive Cancer Center, University of Michigan, Grass Lake, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Center, University of Michigan, Grass Lake, MI;","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074729432","display_name":"Sarit E. Assouline","orcid":"https://orcid.org/0000-0002-7638-1589","observed_orcids":["https://orcid.org/0000-0002-7638-1589"]},"institutions":[{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Sarit E. Assouline","raw_affiliation_strings":["Sir Mortimer B. Davis-Jewish General Hospital, Montreal, QC, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sir Mortimer B. Davis-Jewish General Hospital, Montreal, QC, Canada;","institution_ids":["https://openalex.org/I2801824472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034085838","display_name":"Joseph M. Brandwein","orcid":"https://orcid.org/0000-0001-9095-8789","observed_orcids":["https://orcid.org/0000-0001-9095-8789"]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Joseph M. Brandwein","raw_affiliation_strings":["University of Alberta, Edmonton, AB, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alberta, Edmonton, AB, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036543091","display_name":"Moshe Yair Levy","orcid":"https://orcid.org/0000-0002-2570-6128","observed_orcids":["https://orcid.org/0000-0002-2570-6128"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Moshe Yair Levy","raw_affiliation_strings":["Texas Oncology-Baylor Charles A. Sammons Cancer Center; Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Oncology-Baylor Charles A. Sammons Cancer Center; Dallas, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089074892","display_name":"Robert H. Collins","orcid":"https://orcid.org/0000-0003-0313-2394","observed_orcids":["https://orcid.org/0000-0003-0313-2394"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Collins","raw_affiliation_strings":["University of Texas Southwestern Medical Center, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Southwestern Medical Center, Dallas, TX","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071326806","display_name":"Humberto Lara-Guerra","orcid":"https://orcid.org/0000-0002-9604-2031","observed_orcids":["https://orcid.org/0000-0002-9604-2031"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Humberto Lara-Guerra","raw_affiliation_strings":["Aeglea Biotherapeutics, Austin, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aeglea Biotherapeutics, Austin, TX;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039597999","display_name":"Susan E. Alters","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susan Alters","raw_affiliation_strings":["Aeglea Biotherapuetics, Austin, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aeglea Biotherapuetics, Austin, TX;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084012592","display_name":"Stephen Eckert","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen Eckert","raw_affiliation_strings":["Aeglea Biotherapuetics, Austin, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aeglea Biotherapuetics, Austin, TX;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113683290","display_name":"Scott W. Rowlinson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Scott Rowlinson","raw_affiliation_strings":["Aeglea Biotherapeutics, Austin, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aeglea Biotherapeutics, Austin, TX;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058605525","display_name":"James E. Wooldridge","orcid":"https://orcid.org/0000-0002-9940-8238","observed_orcids":["https://orcid.org/0000-0002-9940-8238"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James Wooldridge","raw_affiliation_strings":["Aeglea Biotherapuetics, Austin, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aeglea Biotherapuetics, Austin, TX;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045250493","display_name":"Aaron David Schimmer","orcid":"https://orcid.org/0000-0003-4023-3899","observed_orcids":["https://orcid.org/0000-0003-4023-3899"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Aaron David Schimmer","raw_affiliation_strings":["Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada;","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":11,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"15_suppl","first_page":"7031","last_page":"7031"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.8393999934196472,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.8393999934196472,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12996","display_name":"Cancer Research and Treatments","score":0.0917000025510788,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12770","display_name":"Amino Acid Enzymes and Metabolism","score":0.010599999688565731,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/relapsed-refractory-acute-myeloid-leukemia","display_name":"relapsed/refractory acute myeloid leukemia","score":0.9319999814033508},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9760000109672546},{"id":"https://openalex.org/keywords/arginine-deprivation","display_name":"arginine deprivation","score":0.9639999866485596},{"id":"https://openalex.org/keywords/arginase-1","display_name":"arginase-1","score":0.9490000009536743},{"id":"https://openalex.org/keywords/arginine-auxotrophy","display_name":"arginine auxotrophy","score":0.8930000066757202},{"id":"https://openalex.org/keywords/ass1","display_name":"ASS1","score":0.4869999885559082},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.6930000185966492},{"id":"https://openalex.org/keywords/anti-drug-antibodies","display_name":"anti-drug antibodies","score":0.8600000143051147},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.6430000066757202},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6230000257492065}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8890029191970825},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.8145084381103516},{"id":"https://openalex.org/C2776012956","wikidata":"https://www.wikidata.org/wiki/Q17125294","display_name":"Hypomethylating agent","level":5,"score":0.6776725649833679},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5478248000144958},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5035931468009949},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.4518815279006958},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4174908697605133},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.41618362069129944},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.15_suppl.7031","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.7031","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.7031","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4405049780","https://openalex.org/W4417016029","https://openalex.org/W2886327945","https://openalex.org/W843220732","https://openalex.org/W2897130762","https://openalex.org/W4389231720","https://openalex.org/W1968261414","https://openalex.org/W9256820","https://openalex.org/W2753622326","https://openalex.org/W2042560747"],"abstract_inverted_index":{"7031":[0],"Background:":[1],"In":[2],"vitro":[3],"studies":[4],"demonstrate":[5],"that":[6,281],"AML":[7,32,52,60,345],"cells":[8],"are":[9,13,333],"arginine":[10,17,29,256,342,350],"auxotrophs":[11],"and":[12,95,193,198,200,236,254,324],"metabolically":[14],"vulnerable":[15],"to":[16,117,247,257,306],"depletion":[18,30,343,348],"(PMID:":[19],"24018014":[20],"&":[21,89,100],"25896651).":[22],"To":[23],"test":[24],"the":[25,126],"clinical":[26,93,296,355],"utility":[27],"of":[28,39,97,128,144,209,259,265,272,279,288,341,349],"in":[31,48,66,102,125,188,207,327,344,357],"we":[33],"performed":[34],"a":[35,41,67,74,269,310,322,336],"phase":[36,68],"1":[37,69,178,225,239],"trial":[38,340,368],"pegzilarginase,":[40],"pegylated,":[42],"recombinant,":[43],"cobalt-substituted,":[44],"human":[45],"arginase":[46],"I":[47],"pts":[49,106,134,154,167,190,196,203,210,267],"with":[50,58,113,309,335],"R/R":[51,59],"or":[53,61,184],"MDS":[54,63],"(NCT02732184).":[55],"Methods:":[56],"Pts":[57],"HMA-refractory":[62],"were":[64,111,155,163,191,298],"enrolled":[65,157],"dose":[70],"escalation":[71],"study":[72],"using":[73],"3+3":[75],"design.":[76],"The":[77,242,330],"primary":[78],"endpoint":[79],"was":[80,123,148,245,282,302],"MTD.":[81],"Other":[82],"endpoints":[83],"included":[84,211],"safety,":[85],"PK,":[86],"PD":[87],"(arginine":[88],"ornithine),":[90],"immunogenicity,":[91],"preliminary":[92],"activity,":[94],"expression":[96,122],"ASS1,":[98],"ASL,":[99],"OTC":[101],"blasts.":[103],"Results:":[104],"Twenty-one":[105],"(19":[107],"AML,":[108],"2":[109,215,220,233,339],"MDS)":[110],"treated":[112],"weekly":[114,317],"pegzilarginase":[115,243],"0.12":[116],"0.48":[118,151],"mg/kg.":[119,152,160],"Low":[120],"ASS1":[121],"observed":[124,149,164,331],"majority":[127],"pt":[129],"samples":[130],"by":[131,321],"rtPCR.":[132],"Eleven":[133],"received":[135],"at":[136,150,158,250,286],"least":[137],"4":[138,166,172,275],"doses.":[139],"One":[140,264],"dose-limiting":[141],"toxicity":[142],"(DLT)":[143],"reversible":[145],"G4":[146],"encephalopathy":[147],"Seven":[153],"then":[156],"0.36":[159,307],"No":[161,295],"DLTs":[162],"but":[165],"discontinued":[168],"treatment":[169,280,289],"before":[170],"receiving":[171],"doses":[173],"(3":[174,195,290],"-":[175,179],"disease":[176],"progression,":[177],"withdrew":[180],"consent).":[181],"Related":[182,205],"serious":[183],"\u2265":[185,251],"Gr3":[186],"AEs":[187,206],"\u22652":[189],"nausea":[192,212],"vomiting":[194,218],"each),":[197],"diarrhea":[199,231],"fatigue":[201,223],"(2":[202],"each).":[204],"\u226510%":[208],"(10":[213],"pts,":[214],"Gr":[216,221,226,234,240],"3),":[217,222,227,235],"(9,":[219],"(7,":[224],"decreased":[228],"appetite":[229],"(6),":[230],"(3,":[232,238],"dizziness":[237],"3).":[241],"t\u00bd":[244],"~39":[246],"49":[248],"hr":[249],"0.24":[252],"mg/kg":[253,308],"depleted":[255],"~10%":[258],"baseline":[260],"for":[261,354],"\u226548":[262],"hrs.":[263],"14":[266],"developed":[268],"low":[270],"titer":[271],"anti-drug":[273],"antibodies":[274],"weeks":[276,291],"after":[277,292],"start":[278],"no":[283],"longer":[284],"detected":[285],"end":[287],"last":[293],"dose).":[294],"responses":[297],"observed.":[299],"Conclusions:":[300],"Pegzilarginase":[301],"well":[303],"tolerated":[304],"up":[305],"manageable":[311],"safety":[312],"profile.":[313],"PK/PD":[314],"data":[315],"support":[316],"dosing,":[318],"as":[319],"confirmed":[320],"rapid":[323],"sustained":[325],"reduction":[326],"blood":[328],"arginine.":[329],"results":[332],"consistent":[334],"recent":[337],"Ph":[338],"(PMID:28900115),":[346],"suggesting":[347],"alone":[351],"is":[352],"insufficient":[353],"activity":[356],"AML.":[358],"Alternative":[359],"approaches":[360],"including":[361],"combination":[362],"therapy":[363],"may":[364],"be":[365],"required.":[366],"Clinical":[367],"information:":[369],"NCT02732184.":[370]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2018-09-27T00:00:00"}